Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program -: North America, 2001

被引:26
作者
Biedenbach, DJ [1 ]
Stephen, JM
Jones, RN
机构
[1] JMI labs, JONES Grp, N Liberty, IA USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1016/S0732-8893(03)00065-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The surveillance of antimicrobial resistance among (beta-hemolytic Streptococcus spp. is an important health care concern due to the serious nature of the diseases that are caused by these pathogens and the emerging antimicrobial resistances. National and international studies have documented diverse rates of resistance to macrolide and lincosamide agents. The SENTRY Antimicrobial Surveillance Program evaluated the resistance rates of beta-hemolytic Streptococcus spp. to several drug classes including erythromycin and clindamycin during the 2001 study year. Twenty-five medical centers in North America contributed 787 isolates from serogroups A (SGA; 397 strains), B (SGB: 318 strains), G (SGG; 45 strains), C (SGC; 19 strains), and F (SGF; eight strains). Isolates were tested at a reference center by broth microdilution using NCCLS methods. A subset of isolates were characterized by molecular methods to determine the presence of erm and mef resistance mechanisms. All isolates were susceptible to beta-lactams, linezolid, vancomycin, chloramphenicol, quinupristin/dalfopristin, and fluoroquinolones. Garenoxacin (MIC90. 0.06 mug/ml) was the most potent fluoroquinolone tested. Tetracycline was inactive against SGB (14.8% susceptible) compared to SGC, SGG, SGF and SGA (48.9-85.6% susceptible). Resistance to erythromycin and clindamycin was highest among SGB isolates with M-phenotypes (mef) representing the majority (59.1%) of strains. Among isolates randomly selected for genotypic characterization, eight strains had mef (A), 16 had erm (A) [subclass erm (TR)], seven had erm (B) and one strain had erm (A) [subclass erm (TR)] and mef (A) present. These data when compared to previous SENTRY program analysis showed macrolide resistance has remained stable over the last live years and M-phenotypes are the most prevalent expression of MLSB resistance in North America. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:291 / 294
页数:4
相关论文
共 18 条
[1]   Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere [J].
Andrews, JI ;
Diekema, DJ ;
Hunter, SK ;
Rhomberg, PR ;
Pfaller, MA ;
Jones, RN ;
Doern, GV .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) :859-862
[2]   Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998:: Survey of macrolide resistance and trend of genotype by RAPD [J].
Avanzini, C ;
Bosio, K ;
Volpe, G ;
Dotti, G ;
Savoia, D .
MICROBIAL DRUG RESISTANCE, 2000, 6 (04) :289-295
[3]   Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis [J].
Bisno, AL ;
Gerber, MA ;
Gwaltney, JM ;
Kaplan, EL ;
Schwartz, RH .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) :113-125
[4]  
CRITCHLEY IA, 2001, DIAGN MICROBIOL INFE, V42, P129
[5]   Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada [J].
de Azavedo, JCS ;
McGavin, M ;
Duncan, C ;
Low, DE ;
McGeer, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3504-3508
[6]   Detection of macrolide resistance mechanisms in Streptococcus pneumonide and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization [J].
Farrell, DJ ;
Morrissey, I ;
Bakker, S ;
Felmingham, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :541-544
[7]   Failure of penicillin in Streptococcus pyogenes pharyngeal infection [J].
Gillespie, SH .
LANCET, 1998, 352 (9145) :1954-1956
[8]   Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci:: report from the SENTRY Antimicrobial Surveillance Program (1997-2000) [J].
Gordon, KA ;
Beach, ML ;
Biedenbach, DJ ;
Jones, RN ;
Rhomberg, PR ;
Mutnick, AH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (02) :157-162
[9]   High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan [J].
Hsueh, PR ;
Teng, LJ ;
Lee, LN ;
Ho, SW ;
Yang, PC ;
Luh, KT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3205-3208
[10]   Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications [J].
Leclercq, R .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :482-492